scispace - formally typeset
P

Philip Costello

Researcher at Medical University of South Carolina

Publications -  173
Citations -  9362

Philip Costello is an academic researcher from Medical University of South Carolina. The author has contributed to research in topics: Angiography & Pulmonary embolism. The author has an hindex of 49, co-authored 173 publications receiving 8832 citations. Previous affiliations of Philip Costello include York University & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

The national lung screening trial: Overview and study design

Constantine A. Gatsonis, +1336 more
- 01 Jan 2011 - 
TL;DR: The National Lung Screening Trial (NLST) is a randomized multicenter study comparing low-dose helical computed tomography with chest radiography in the screening of older current and former heavy smokers for early detection of lung cancer.
Journal ArticleDOI

Right Ventricular Enlargement on Chest Computed Tomography A Predictor of Early Death in Acute Pulmonary Embolism

TL;DR: In patients with acute PE, RV enlargement on reconstructed CT 4-CH view helps predict early death on multidetector-row chest CT.
Journal ArticleDOI

CT angiography for diagnosis of pulmonary embolism: state of the art.

TL;DR: While the introduction of multi-detector row technology has improved CT diagnosis of PE, it has also challenged its users to develop strategies for optimized contrast material delivery, reduction of radiation dose, and management of large-volume data sets created at those examinations.
Journal ArticleDOI

Right Ventricular Enlargement on Chest Computed Tomography Prognostic Role in Acute Pulmonary Embolism

TL;DR: Right ventricular enlargement on the reconstructed CT 4-CH views predicts adverse clinical events in patients with acute PE and Ventricular CT measurements obtained from 4- CH views are superior to those from axial views for identifying high-risk patients.
Journal ArticleDOI

CT of coronary artery disease.

TL;DR: Recent studies indicate that CT angiography may also be suited for other clinical applications such as triage of patients with acute coronary syndrome and inconclusive clinical presentation, patients with symptomatic chest pain, and intermediate risk profile or cardiac risk stratification in asymptomatic patients.